Chia-Yi Lee

Chia-Yi Lee

Auto-generated profile, based on publicly available information

Chia-Yi Lee

Department of Genetics, Wu Tsai Institute, Yale University School of Medicine, New Haven, CT, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2021 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
WLWan-Chen Li
Wan-Chen Li
CLChia-Yi Lee
Chia-Yi Lee
WLWei-Hsuan Lan
Wei-Hsuan Lan
TWTai-Ting Woo
Tai-Ting Woo
HLHou-Cheng Liu
Hou-Cheng Liu
Ting-fang WangTing-fang Wang
Ting-fang Wang
Significance: Sexual eukaryotes fall into two groups with respect to their RecA-like recombinases. The first group possesses Rad51 (ubiquitous) and Dmc1 (meiosis-specific), which cooperate to conduct interhomolog recombination in zygotes with high sequence heterogeneity. Interestingly, Dmc1 was lost from the second group of eukaryotic organisms. Here we used the industrial workhorse fungus Trichoderma reesei to address if and how Rad51-only eukaryotes carry out hybrid meiosis. We show that T. reesei Rad51 ( Tr Rad51) is indispensable for interhomolog recombination during meiosis and that Tr Rad51, like Saccharomyces cerevisiae Dmc1, possesses a better mismatch tolerability than S. cerevisiae Rad51. Our results indicate that the ancestral Tr Rad51 evolved to acquire Dmc1-like properties by adopting multiple structural variations in the L1 and L2 DNA-binding loops.

15 October 2025 in medRxiv
Verified
Preprint
Open access
PDF file
CLChia-Yi Joy Lee
Chia-Yi Joy Lee
ARAshvin Ravi
Ashvin Ravi
THTzu-Chieh Huang
Tzu-Chieh Huang
BWBriana Wyman
Briana Wyman
ZLZiyu Liu
Ziyu Liu
KBKristen J. Brennand
Kristen J. Brennand
Although defined by end-stage neuronal loss, neurodegenerative diseases are increasingly hypothesized to be initiated by early microglial dysfunction. Genetic risk for Alzheimer′s disease (AD) is particularly highly enriched for non-coding variants located in microglia-specific regulatory regions. Yet, the linkage-dense nature of these variants limits their functional interpretation. To elucidate how risk variants influence microglial gene regulation, we contrast fine-mapping of AD genome-wide association study (GWAS) loci by four complementary methods, and resolve a highly concordant set of putative causal variants. In total, 11,550 candidate regulatory sequences (CRSs), nominated from GWAS (n = 2,183), microglial expression quantitative trait loci (QTL) (n = 5,721) and microglial chromatin accessibility QTL (n = 1,519), are screened en masse by massively parallel reporter assay (MPRA) in human induced pluripotent stem cell (hiPSC)–derived microglia (iMGL) and immortalized HMC3 cell lines. Distinct sets of functional variants are identified between cellular models, underscoring the importance of using physiologically relevant microglia for variant interpretation. Functional regulatory variants (frVar) are enriched in promoters and splicing regions, with over half predicted to disrupt transcription factor (TF) binding. The affected TFs yield distinct regulatory modules, the first with an inflammatory program and the second with a DNA stress–response network. Mapping frVar to their predicted target genes reveals enrichment for biological processes related to amyloid biology, immune signaling, and neuron–microglia communication. Notably, we pinpoint functional variants within several understudied AD loci, including TSPOAP1, providing direct evidence for causal regulatory effects. Together, these findings establish the first large-scale microglial-context MPRA, define a microglial regulome underlying AD genetic risk, and provide a functional framework to refine noncoding variant interpretation and therapeutic target discovery.

14 May 2026 in Nature Communications
Verified
Journal Article
Open access
XHXia Han
Xia Han
GRGregory M. Rosenberg
Gregory M. Rosenberg
VKVivianne M. Kisling
Vivianne M. Kisling
TZTao Zhang
Tao Zhang
CLChia-Yi Lee
Chia-Yi Lee
JRJessica Rexach
Jessica Rexach
The accumulation of abnormal tau protein selectively affects distinct brain regions and specific populations of neurons and glial cells in tau-related dementias, such as Alzheimer’s disease, Pick’s disease and progressive supranuclear palsy. Although the three disorders share the feature of tau protein pathology, the regulatory circuitry of non-coding genetic variants underlying risk-associated cell states remains to be elucidated. Using paired single-nucleus profiling of chromatin accessibility and gene expression across the three conditions, we define cell-type-specific cis-regulatory elements across six cell types and fifty subclasses. Comparing disease-dynamic cis-regulatory elements across three disorders, we find that glia overrepresent disorder-specific gene regulation related to dynamic cellular response to stress. We show that human genetic variants affecting microglial gene regulation converge into distinct and co-regulated modules affecting specific cellular functions. Moreover, polygenic risk modifiers are maximally co-accessible in disorder-specific glial states, modifying distinct pathways such as sphingomyelin regulation in Pick’s disease. Our study informs glial regulators linked to polygenic modifiers of primary tauopathy, establishing modifiable pathways governing resilience.